Orion Portfolio Solutions LLC Has $4.20 Million Holdings in Colgate-Palmolive (NYSE:CL)

Orion Portfolio Solutions LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 6.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,240 shares of the company’s stock after purchasing an additional 2,943 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Colgate-Palmolive were worth $4,204,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $32,000. Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the fourth quarter valued at about $32,000. Finally, Wintrust Investments LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth about $33,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $92.73 on Monday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market cap of $75.25 billion, a price-to-earnings ratio of 26.34, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The stock’s 50-day moving average is $89.69 and its 200-day moving average is $93.52. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business posted $0.87 EPS. Equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has approved a stock repurchase program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be issued a dividend of $0.52 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is presently 59.09%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CL. Barclays raised their target price on shares of Colgate-Palmolive from $83.00 to $89.00 and gave the company an “equal weight” rating in a research note on Thursday. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a report on Friday, March 14th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. UBS Group dropped their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $102.06.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.